scholarly journals 中西醫結合述評

Author(s):  
Weibo LU

LANGUAGE NOTE | Document text in Chinese; abstract also in English.中西醫結合包含中醫和西醫之間的團結合作,但更重要的是中醫學和西醫學之間的互相結合。在世界上對傳統醫學曾有過三種方針,即“否定”,“容忍”和“平行”的方針,均不能充分發揮傳統醫學的作用和潛力。中國採取“結合”的方針,較好地解決了這一問題,不僅滿足當前醫療工作的需要,更重要的是在科學研究中,強調創新,兩種醫學的觀點、方法、優勢互補,獲得大量新的研究成果,如針刺原理和針麻研究,青萬素的發現,瘀血證研究等。雖然現代醫學是主流醫學,但尚不足以解決所有問題,如慢性病,老年病等。用結合的思想可以更好地解決各種難題,使醫學科學更快地向前發展,造福於人民。What attitude should we take toward traditional medicine? There have been three types of policies in this regard all over the world. First, the excluding policy prohibits practicing any traditional medicine. Traditional physicians are not qualified to possess the title of physician, and their practice is illegal. Second, the tolerating policy does not make illegal traditional medical practice, but it does not formally affirm the practice. Third, the paralleling policy allows both traditional and modem medical practices, but their use may not overlap. For example, traditional physicians may not use modem medical facilities.Since the establishment of the People’s Republic of China in 1949, a unique policy of integration has been adopted in China. This policy assumes that both traditional Chinese medicine and modern Western medicine have strengths and weaknesses. It requires that both types of medicine be integrated so as to develop more effective methods in treating diseases and preserving health.There are two senses of the integration of traditional Chinese and modern Western medicine. The first sense refers to the integration of the two types of the physicians, i.e., the cooperation between traditional Chinese practitioners and modern Western medical professionals. The second sense refers to the integration of the two disciplines; i.e., to use both traditional Chinese and modern Western medical theories and practices to create new forms of diagnostic and therapeutic approaches and means. The hope was to have the perspectives, methods, and solutions of both types of medicine complement each other.Under the integrating policy, traditional Chinese medicine has been developed tremendously in mainland China. 30 traditional Chinese medical colleges, 2457 traditional Chinese medical hospitals, and 170 traditional Chinese medical research institutions have been established. A number of well-known medical achievements, such as acupunctural analgesia and anesthesia, the discovery of a new type of anti-malaria drug - Qinghaosu (artemisinin), and the study of blood stasis syndrome, have been made by following the integrating strategy.With the rapid growth and development of the diagnostic and therapeutic technologies in modern Western medicine, some individuals are doubtful of the prospect of traditional Chinese medicine and of the necessity of China’s integrating strategy. However, no matter how advanced modern Western medicine as a form of medicine has become, it will not be able to handle all diseases or medical problems effectively and appropriately. The human body and medical reality are too complicated to be fixed by modern medicine once and for all. For instance, in the present time, chronic and geriatric diseases pose perplexing challenges to modern medicine. Possibilities are always open for traditional Chinese medicine as well as the integrated traditional Chinese and modern medicine to make their valuable contributions.DOWNLOAD HISTORY | This article has been downloaded 69 times in Digital Commons before migrating into this platform.

2021 ◽  
Vol 07 ◽  
Author(s):  
Sumel Ashique ◽  
Navjot K Sandhu

: The nCOVID-19 virus has become the most threatening infections disease all over the world. From the beginning till today a large number of researches is going on to develop appropriate therapeutics that can prevent and cure this viral infection successfully. But unfortunately, modern western medicine could not find any effective drug having no toxic effects on host cell. TCM (traditional Chinese Medicine) has shown promising effect against nCOVID-19. This TCM contains natural occurring herbal decoctions which showed promising blocking of viral progression in host cell. These ayurvedic formulations containing homeopathic medicine, unani medicine and yoga to challenge the virus. The traditional medicine system is unable to cure properly but it can be a possible preventing strategy to stop this virus pandemicity. This review focuses how the ayurvedic medicines, homeopathic treatment strategies and yoga can impact to prevent the viral infection.


2022 ◽  
Vol 67 (4) ◽  
pp. 121-129
Author(s):  
Tan Zifu ◽  
Li Jiaquan ◽  
Zhang Juan

The pathological basis of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is severe coronary stenosis, unstable plaque erosion, and rupture, resulting in coronary blood flow reduction and myocardial ischemia, leading to acute thrombosis cardiovascular disease events. This subject intends to study the treatment of NSTE-ACS patients with blood stasis and toxin syndrome by Qingre Jiedu Huoxue Huayu Decoction, observe its clinical efficacy, and explore the effects of serum lipoprotein phospholipase A2 (Lp-PLA2) and tumor necrosis factor- α (TNF- α), the effect of placental growth factor (PIGF) expression. In this study, 100 patients with blood stasis and toxin syndrome of NSTE-ACS treated in the cardiovascular department of Enshi National Hospital from August 2020 to August 2021 were selected as the research object. They were randomly divided into traditional Chinese medicine comprehensive treatment groups and conventional western medicine control groups, with 50 cases. The conventional western medicine control group was treated with hydroclopidogrel tablets orally, and the comprehensive treatment group of traditional Chinese medicine combined with Qingre Jiedu Huoxue Huayu formula orally. The patients in both groups were treated for four weeks. The results showed that after treatment, the practical clinical rate of the comprehensive treatment group was significantly higher than that of the conventional western medicine control group. After treatment, the TCM syndrome score, angina pectoris attack duration, and angina pectoris attack frequency, myocardial zymogram index level, serum Lp-PLA2 and TNF of the two groups were measured- α. The levels of PIGF were significantly lower than those before treatment. The decline of the above indexes in the comprehensive treatment group of traditional Chinese medicine was significantly better than that in the control group of conventional Western Medicine (P<0.05). The incidence of MACE events in the TCM Comprehensive treatment group was significantly lower than that in the conventional western medicine control group (P <0.05).


2009 ◽  
Vol 17 (04) ◽  
pp. 531-546 ◽  
Author(s):  
SHUZHEN GUO ◽  
JIANXIN CHEN ◽  
HUIHUI ZHAO ◽  
WEI WANG ◽  
JIANQIANG YI ◽  
...  

Building an animal model for a disease is a better avenue to understand the inner mechanism of it. Traditional Chinese Medicine accumulated much practical experience and a large amount of literature to heal diseases during the past 3000 years. However, as there is no available animal model for TCM research because syndrome, the core of TCM theory, it is hard to be diagnosed from animals. In this paper, we present a novel strategy to build and evaluate an animal model for syndrome in TCM in the context of a disease. We first carried out a clinical epidemiology survey for a syndrome (Blood stasis syndrome, BSS) diagnosed by TCM experts in the context of a disease (Unstable angina, UA). Meanwhile, the blood samples of patients included in the survey were collected and measured as physical and chemical specifications by laboratory examinations. Alternatively, we used supervised data mining methods to build association between the specifications and the syndrome in the context of UA. The accuracy of classification was used to evaluate performance of the association built. Finally, we built an animal model for myocardial ischemia and validated the model by established diagnosis criterion of myocardial ischemia. Furthermore, the built association was used to evaluate whether an animal is with BSS. The results indicated that the strategy successfully evaluates and separates the animal model for syndrome in TCM from the counterpart for myocardial ischemia. The novel strategy presented in the paper provides a better insight to understand the nature of syndrome in TCM and pave a basis for personalized therapies of UA.


RSC Advances ◽  
2017 ◽  
Vol 7 (89) ◽  
pp. 56471-56483
Author(s):  
Jing-Jing Xu ◽  
Feng Xu ◽  
Shu-Jie Shen ◽  
Teng Li ◽  
Yi-Fan Zhang ◽  
...  

Dynamic changes of the metabolic network during the evolution of a syndrome based on the toxic heat and blood stasis syndrome (THBSS) rat model have been elucidated for the first time.


2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Ye Huang ◽  
Jing-Shang Wang ◽  
Hui-jun Yin ◽  
Ke-ji Chen

Blood stasis syndrome (BSS), a comprehensive pathological state, is one of the traditional Chinese medicine syndromes of coronary heart disease (CHD). In our previous study, we investigated that FcγRIIIA (also called CD14+CD16+monocyte subpopulation) is one of the differentially expressed genes related to CHD patients and its possible role in the atherosclerotic formation and plaque rupture. However, whether or not the deregulation of CD14+CD16+monocyte subpopulation expression is implicated in the pathogenesis of CHD patients with BSS has not yet been elucidated. In this study, we found that there was no significant difference between CHD patients with BSS and non-BSS in CD14+CD16+monocyte subpopulation at gene level. Moreover, the protein level of CD14+CD16+monocyte subpopulation in CHD patients with BSS was increased significantly when compared to the CHD patients with non-BSS. Additionally, the level of inflammatory cytokines downstream of CD14+CD16+monocyte subpopulation such as TNF-αand IL-1 in sera was much higher in CHD patients with BSS than that in CHD patients with non-BSS. Taken together, these results indicated that CD14+CD16+monocyte subpopulation was implicated in the pathogenesis of CHD patients with BSS, which may be one of the bases of the essence of BSS investigation.


2018 ◽  
Vol 4 (1) ◽  
pp. 24-27
Author(s):  
Ramanpreet Walia ◽  
Abhay Verma

Plants and fungi are a vital part of healthcare. Over 80% of the global population rely on traditional medicine, much of which is based on plant remedies. Traditional Chinese medicine alone uses over 5,000 plant species. There is a healing quality in nature, which has been known for centuries, be it taking time to smell the roses, meditating on a mountain, lying in a wildflower field, strolling by a meandering stream, or hiking in ancient redwood groves. Hippocrates, the father of modern medicine, recognized this powerful attribute in his humbling statement: Nature cures—not the physician.   Hippocrates


2018 ◽  
Vol 01 (03) ◽  
pp. 171-180 ◽  
Author(s):  
Wenxian Liu ◽  
Linwei Lu ◽  
Cheng Ma ◽  
Chen Yan ◽  
Zhengxiao Zhao ◽  
...  

“Traditional Chinese Medicine” (TCM; Zhong Yi) is a concept that keeps evolving with the change of times and clinical practice. From the aspect of the category of modern science, there were not appropriate boundaries set for the literature, history and philosophy in the realm of Chinese traditional academics. Thanks to the eastward spread of Western culture and science, the category of disciplines in modern times then came into being. In order to be listed in the system of modern disciplines, traditional disciplines have always been trying to redefine themselves, and “TCM,” of course, is involved. Considering the fact that “TCM” is now an academic discipline in the field of medicine, here we reviewed not only the transition of the concept of “TCM” from a primitive and then a hierarchical medical term to a relatively full-fledged one that is, to some extent, opposite to the concept of Western Medicine or modern medicine, from a narrow medical term that is peculiar to Han Medicine to a broad one that pertains to Han Medicine along with ethnic traditional medicines in China, but also the transition of the development from merely highlighting TCM and then equally emphasizing TCM together with modern medicine to comprehensively converging TCM, modern medicine and Integrative Medicine, which contributes to the evolution from the dominance of TCM, the coexistence of TCM and modern medicine, the confluence of TCM and modern medicine, and finally to the integration of TCM and modern medicine. In addition, we introduced pioneering medical concepts, epistemology and methodology such as Chinese Traditional Medicine (CTM; Da Zhong Yi), Trichotomy (San Fen Fa), Five Key Elements (Wu Yao Su) and Three-dimensional Integration (San Rong He), proposed the potential future direction of medicine, stressed the importance of taking the essence and discarding the dregs in TCM, and appreciated those who are able to perceive similarities in differences. We looked forward to reconstructing the system of TCM by the integration of the part that is unconsciously ahead of modern medicine and that has already reached consensus with modern medicine from all the traditional medicines in China, which would promise a brand new system of medicine harmoniously integrating traditional medicine and modern medicine.


2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Xuefeng Shi ◽  
Dawei Zhu ◽  
Stephen Nicholas ◽  
Baolin Hong ◽  
Xiaowei Man ◽  
...  

Background. Traditional, complementary, and alternative medicine (TCAM) has attracted increasing attention in developed countries, but its mainstream status in China, the home of TCAM, is unclear. Over the period of 2004–2016, we analyze the health resources and health resource utilization of traditional medicine in traditional Chinese medicine (TCM) hospitals in China. Methods. Over 2004–2016, we obtained data from all TCM hospitals in all Chinese provinces to create a hospital-based, longitudinal dataset. TCM health resources and their utilization were measured by two outcome variables: (1) primary outcome variables comprising the proportion of TCM physicians, TCM pharmacists, revenue from TCM drugs, and TCM prescriptions and (2) the secondary outcome variables, as proxies of westernization for TCM hospitals, comprising the number of medical equipment above RMB 10,000 and the proportion of surgery in inpatient visits. We used linear regression models with hospital-fixed effects to analyze time trends for the outcome variables. Results. The number of public TCM hospitals remained stable from 2004 to 2016, while the number of private TCM hospitals increased from 294 in 2004 to 1560 in 2016. There was a small percentage increase in the proportion of TCM physicians (0.280%), TCM pharmacists (0.298%), and revenue from Chinese medicines (0.331%) and TCM prescriptions (1.613%) per hospital per year. Chinese drugs accounted for less than a half of the total drug prescriptions, and accordingly, just one-third of the drug revenue was from Chinese medicines at TCM hospitals. The proportions of physicians, pharmacists, revenue from Chinese drug sales, and traditional medicine prescriptions never reach the 60% benchmark target for mainstream in TCM hospitals. As proxies for Western medicine practices in TCM hospitals, the number of medical equipment above RMB 10,000 rapidly rose by over 13 percent per hospital per year, but the proportion of inpatient surgeries declined by 0.830 percentage points per hospital per year, reflecting a mixed trend in the use of Western medicine practices. Conclusion. For the 2004–2016 period, traditional medicine, although making progress towards the mainstream benchmark of 60% TCM services, was still not mainstream at TCM hospitals.


Sign in / Sign up

Export Citation Format

Share Document